Isothermal Nucleic Acid Amplification Technology (INAAT) Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2027

 

In molecular biology, RNA sequences are amplified using nucleic acid sequence-based amplification. The term "isothermal nucleic acid amplification technology" (INAAT) refers to a group of techniques that include signal-mediated amplification of RNA, nucleic acid sequence-based amplification, transcription-mediated amplification, and others. The market is anticipated to expand quickly during the forecast period as a result of these techniques for amplifying RNA sequences using isothermal nucleic acid amplification technology.

The Isothermal Nucleic Acid Amplification Technology (INAAT) Market was positively impacted by the COVID-19 pandemic. Given that INAAT offers the straightforward operation, quick detection, and precise results. It consequently becomes more suitable for both urban and rural primary testing centers. Since PCR-based nucleic acid detection technology takes time and requires specialized equipment, INAAT is in high demand.

Additionally, PCR is challenging to use in first-level medical facilities. Due to the late appearance of antibodies, which makes early virus diagnosis challenging, antibody-based detection has limitations. In contrast, antigen-based detection has low sensitivity and frequently results in a high false-negative rate.

The rapid, exponential detection of a nucleic acid target sequence is made possible by Isothermal Nucleic Acid Amplification Technology (INAAT) Market techniques. Thermal cycling is not a restriction on this process. Nucleic acid-based on-site diagnostics are improved and become more sensitive when isothermal amplification is incorporated into microsystems or portable devices. Furthermore, Isothermal Nucleic Acid Amplification Technology (INAAT) Market can achieve amplification in 15–16 minutes by using various enzymatic techniques to divide the two DNA strands before replication.

Throughout the forecast period, it is anticipated that the rising prevalence of infectious diseases will significantly fuel market growth. The need for better diagnostic and treatment methods in healthcare facilities has increased due to the rise in infectious diseases like influenza, HIV, tuberculosis, etc.

Key Players

The isothermal nucleic acid amplification technology (INAAT) market is dominated by companies such as Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN.